首页|CCL23与急性缺血性脑卒中患者疾病严重程度及短期预后的关系分析

CCL23与急性缺血性脑卒中患者疾病严重程度及短期预后的关系分析

扫码查看
目的 探究CC类趋化因子配体23(CCL23)与急性缺血性脑卒中(acute ischemic stroke,AIS)患者疾病严重程度及短期预后的关系。方法 选取2020年3月-2023年3月在黄河科技学院附属医院就诊的100例AIS患者作为研究组,另选取同期在本院行健康体检的志愿者110例作为对照组。收集研究对象的临床资料并进行比较分析;酶联免疫吸附测定(ELISA)法检测血清中CCL23水平;AIS患者疾病严重程度依据美国国立卫生研究院卒中量表(NIHSS)进行评估(轻度组、中度组、重度组);治疗3个月后,AIS患者预后转归情况依据改良Rankin量表(mRS)进行评估(预后良好组、预后不良组);logistic回归分析影响AIS患者预后的影响因素;受试者工作特征(receiver operating characteristics,ROC)曲线分析CCL23对AIS患者预后的预测价值。结果 与对照组相比,研究组CCI23水平均显著升高,差异有统计学意义(P<0。05);不同疾病严重程度组间的CCL23表达水平,差异有统计学意义(P<0。05);与预后不良组相比,预后良好组的CCL23表达水平显著降低,差异有统计学意义(P<0。05)。经过对预后良好组与预后不良组的临床资料进行比较,发现预后不良组的高血压史、收缩压、白细胞计数、单核计数、血小板计数显著高于预后良好组(P<0。05)。通过多因素logistic回归分析结果显示,高血压史、收缩压、白细胞计数、单核细胞计数、血小板计数、CCI23均为AIS患者发生不良预后的独立危险因素(P<0。05)。ROC曲线分析结果显示,CCL23预测AIS患者预后不良发生的曲线下面积为0。900,其灵敏度为88。14%,特异度为80。49%。结论 CCI23可参与AIS的发生和发展,且CCI23对AIS患者预后不良发生的预测效能较高。
Analysis of relationship between CCL 23 and disease severity and short-term outcomes in patients with acute ischemic stroke
Objective To investigate the relationship between C-C motif chemokine ligand 23(CCL23)levels and the disease severity and short-term prognosis of patients with acute ischemic stroke(AIS).Methods Totally 100 AIS pa-tients treated from March 2020 to March 2023 at Huanghe Science and Technology College Affliated Hospital were se-lected as the study group.Additionally,110 healthy volunteers who underwent medical check-ups at the same hospital during the same period were selected as the control group.Clinical data of the subjects were collected for comparative a-nalysis.Serum CCL23 levels were detected using the enzyme linked immunosorbent Assay(ELISA)method.The sever-ity of the AIS was assessed using the national institutes of health stroke scale(NIHSS),categorized into mild,moder-ate,and severe groups.Three months after treatment,the prognosis of AIS patients was assessed using the modified rankin scale(mRS),classifying them into good prognosis and poor prognosis groups.Logistic regression analysis was employed to identify factors affecting the prognosis of AIS patients.The predictive value of CCL23 on the prognosis of AIS patients was analyzed using the receiver operating characteristic(ROC)curve.Results In the study group,serum CCL23 levels were significantly higher compared to the control group(P<0.05).There were significant differences in the expression levels of CCL23 among different disease severity groups(P<0.05).Compared to the poor prognosis group,the good prognosis group exhibited significantly lower levels of CCL23(P<0.05).Upon comparing clinical data between the good prognosis and poor prognosis groups,it was found that the history of hypertension,systolic blood pres-sure,white blood cell count,monocyte count,and platelet count were significantly higher in the poor prognosis group(P<0.05).Multivariate logistic regression analysis indicated that history of hypertension,systolic blood pressure,white blood cell count,monocyte count,platelet count,and CCL23 were independent risk factors for poor prognosis in AIS pa-tients(P<0.05).The ROC curve analysis showed that the AUC of CCL23 for predicting the adverse prognosis occurrence in AIS patients was 0.900,with a sensitivity of 88.14% and a specificity of 80.49%.Conclusion CCL-23 may be in-volved in the occurrence and development of AIS,and CCL-23 is highly effective in predicting the poor prognosis of AIS patients.

Acute ischemic strokeC-C motif chemokine ligand 23SeverityPrognosis

张铁山、邢汝月、王冬梅、马婉嫕

展开 >

黄河科技学院附属医院急诊科,郑州 450000

急性缺血性脑卒中 CC类趋化因子配体23 严重程度 预后

2024

医药论坛杂志
中华预防医学会,河南省医学情报研究所

医药论坛杂志

影响因子:0.47
ISSN:1672-3422
年,卷(期):2024.45(19)